{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:24:45Z","timestamp":1792758285836,"version":"4.5.0"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jaut.2018.07.018","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T09:16:41Z","timestamp":1533115001000},"page":"24-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":371,"special_numbering":"C","title":["A comprehensive review on adult onset Still's disease"],"prefix":"10.1016","volume":"93","author":[{"given":"Roberto","family":"Giacomelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.07.018_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/07853890.2014.971052","article-title":"Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options","volume":"47","author":"Kadavath","year":"2015","journal-title":"Ann. Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/adc.16.87.156","article-title":"On a form of chronic joint disease in children","volume":"16","author":"Still","year":"1941","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.jaut.2018.07.018_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1742-1241.2007.01393.x","article-title":"Adult-onset Still's disease","volume":"63","author":"Cagatay","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jaut.2018.07.018_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","article-title":"Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors","volume":"31","author":"Gasparyan","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2018.07.018_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.54.7.587","article-title":"Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France","volume":"54","author":"Magadur-oly","year":"1995","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2188\/jea.7.221","article-title":"Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan","volume":"7","author":"Wakai","year":"1997","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.jaut.2018.07.018_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009740510026616","article-title":"Epidemiology and outcome of adult-onset Still's disease in Northern Norway","volume":"35","author":"Evensen","year":"2006","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib10","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","article-title":"Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients","volume":"35","author":"Sfriso","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/ard.2005.042143","article-title":"Diagnosis and management of adult onset Still's disease","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib12","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3143\/geriatrics.29.960","article-title":"Two cases of adult onset of Still's disease in the elderly","volume":"29","author":"Ichiki","year":"1992","journal-title":"Jpn. J. Geriatr."},{"key":"10.1016\/j.jaut.2018.07.018_bib13","first-page":"791","article-title":"Adult onset Still's disease in the elderly: a report of two cases","volume":"12","author":"Wouters","year":"1985","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2018.07.018_bib15","first-page":"489","article-title":"Association between HLA-DR B1 and clinical features of adult onset Still's disease in Korea","volume":"21","author":"Joung","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib16","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.1780241203","article-title":"HLA-Bw35 and prognosis in adult Still's disease","volume":"12","author":"Terkeltaub","year":"1981","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/art.1780290316","article-title":"Adult-onset Still's disease. Disease course and HLA associations","volume":"29","author":"Wouters","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib18","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease","volume":"40","author":"Fujii","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.018_bib19","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar1930","article-title":"A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population","volume":"8","author":"Sugiura","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2018.07.018_bib20","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4239","article-title":"A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease","volume":"15","author":"Wang","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2018.07.018_bib21","article-title":"Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes","author":"Sighart","year":"2017","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2018.07.018_bib22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/ard.47.9.764","article-title":"Adult onset Still's disease and viral infections","volume":"47","author":"Wouters","year":"1988","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/ard.59.6.490c","article-title":"Rubella infection in adult onset Still's disease","volume":"59","author":"Escudero","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib24","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1086\/526785","article-title":"Adult-onset Still's disease presenting as fever of unknown origin in a patient with HIV infection","volume":"46","author":"DelVecchio","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib25","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1086\/319342","article-title":"Adult Still's disease associated with Mycoplasma pneumonia infection","volume":"32","author":"Perez","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1684\/ejd.2016.2745","article-title":"Macrophage activation syndrome triggered by disseminated tuberculosis with tuberculous gumma in a patient with adult-onset Still's disease and Good's syndrome","volume":"26","author":"Matsuura-Otsuki","year":"2016","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1179\/acb.2008.030","article-title":"Bartonella endocarditis mimicking adult Still's disease","volume":"63","author":"De Clerck","year":"2008","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.jaut.2018.07.018_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.revmed.2013.02.014","article-title":"Adult-onset Still's disease as a manifestation of malignancy: report of a patient with melanoma and literature review","volume":"35","author":"Liozon","year":"2014","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jaut.2018.07.018_bib29","doi-asserted-by":"crossref","first-page":"E1342","DOI":"10.3390\/ijms17081342","article-title":"TLR4 endogenous ligand S100A8\/A9 levels in adult-onset Still's disease and their association with disease activity and clinical manifestations","volume":"17","author":"Kim","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2018.07.018_bib30","first-page":"396","article-title":"Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease","volume":"25","author":"Hoshino","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib31","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib32","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease","volume":"31","author":"Chen","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib33","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar4193","article-title":"Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease","volume":"15","author":"Chen","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2018.07.018_bib34","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.3390\/biomedicines5030056","article-title":"CD64: an attractive immunotherapeutic target for M1-type macrophage mediated chronic inflammatory diseases","volume":"5","author":"Akinrinmade","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaut.2018.07.018_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/03009742.2011.644325","article-title":"Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease","volume":"41","author":"Komiya","year":"2012","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/rheumatology\/38.5.477","article-title":"High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease","volume":"38","author":"Matsui","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.018_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clinbiochem.2008.01.008","article-title":"The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease","volume":"41","author":"Zou","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jaut.2018.07.018_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12026-014-8563-7","article-title":"sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia","volume":"60","author":"Colafrancesco","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2018.07.018_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1189\/jlb.3RU0316-144R","article-title":"Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage","volume":"100","author":"Ushach","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2018.07.018_bib40","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3899\/jrheum.091120","article-title":"Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease","volume":"37","author":"Jung","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1535370216681551","article-title":"Calprotectin in rheumatic diseases","volume":"242","author":"Ometto","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib42","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1080\/14728222.2016.1251582","article-title":"MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development","volume":"20","author":"Bloom","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jaut.2018.07.018_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.biopha.2017.05.126","article-title":"Inflammasomes, the cardinal pathology mediators are activated by pathogens, allergens and mutagens: a critical review with focus on NLRP3","volume":"92","author":"Patel","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jaut.2018.07.018_bib44","first-page":"3364","article-title":"Human parvovirus B19 nonstructural protein NS1 activates NLRP3 inflammasome signaling in adult-onset Still's disease","volume":"17","author":"Chen","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jaut.2018.07.018_bib45","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3899\/jrheum.161354","article-title":"Elevated expression of the NLRP3 inflammasome and its correlation with disease activity in adult-onset still disease","volume":"44","author":"Hsieh","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib46","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3899\/jrheum.111500","article-title":"Natural killer cell cytolytic function in Korean patients with adult-onset Still's disease","volume":"39","author":"Park","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib47","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/art.34514","article-title":"Natural killer T cell deficiency in active adult-onset Still's disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells","volume":"64","author":"Lee","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib48","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.181.3.1627","article-title":"Cutting edge: priming of NK cells by IL-18","volume":"181","author":"Chaix","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib50","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/1744666X.2017.1372194","article-title":"Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets?","volume":"13","author":"Ruscitti","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","article-title":"Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart","volume":"61","author":"Jamilloux","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2018.07.018_bib52","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis","volume":"37","author":"Rau","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib53","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/rheumatology\/keq284","article-title":"Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease","volume":"49","author":"Chen","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.018_bib54","article-title":"Th17 response and inflammatory autoimmune diseases","volume":"2012","author":"Waite","year":"2012","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.jaut.2018.07.018_bib55","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/03008200903461462","article-title":"The associations of circulating CD4+CD25high regulatory T cells and TGF-\u03b2 with disease activity and clinical course in patients with adult-onset Still's disease","volume":"51","author":"Chen","year":"2010","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.jaut.2018.07.018_bib56","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-005-0138-5","article-title":"A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis","volume":"25","author":"Pay","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/03009740701340081","article-title":"Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in Korean patients with adult-onset Still's disease","volume":"36","author":"Youm","year":"2007","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib58","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imr.12617","article-title":"The role of the interleukin-1 family in trained immunity","volume":"281","author":"Moorlag","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/782382","article-title":"The role of IL-1\u03b2 in the bone loss during rheumatic diseases","volume":"2015","author":"Ruscitti","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jaut.2018.07.018_bib61","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1586\/1744666X.2016.1168293","article-title":"IL-1\u03b2 at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?","volume":"12","author":"Giacomelli","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-015-0228-7","article-title":"Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey","volume":"10","author":"Rossi-Semerano","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib63","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fphar.2016.00380","article-title":"A snapshot on the on-label and off-label use of the Interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study","volume":"7","author":"Vitale","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2018.07.018_bib64","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/ar3366","article-title":"Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study","volume":"13","author":"Laskari","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2018.07.018_bib65","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/ard.2003.016428","article-title":"Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis","volume":"63","author":"Rooney","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib66","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2008.093781","article-title":"Lymph node IL-18 expression in adult-onset Still's disease","volume":"68","author":"Conigliaro","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib67","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib68","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/rheumatology\/keq397","article-title":"Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis","volume":"50","author":"Priori","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.018_bib69","article-title":"IL-18 serum level in adult onset Still's disease: a marker of disease activity","volume":"2012","author":"Colafrancesco","year":"2012","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.jaut.2018.07.018_bib70","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3899\/jrheum.090662","article-title":"Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases","volume":"37","author":"Maruyama","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset Still's disease: comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib72","first-page":"653","article-title":"Interleukin 6: a possible marker of disease activity in adult onset Still's disease","volume":"14","author":"Scheinberg","year":"1996","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib73","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10067-012-1952-1","article-title":"Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome","volume":"31","author":"Kasama","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib74","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13075-015-0773-4","article-title":"Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease","volume":"17","author":"Han","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2018.07.018_bib75","doi-asserted-by":"crossref","first-page":"46652","DOI":"10.1038\/srep46652","article-title":"Elevated circulating levels of the interferon-\u03b3-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2018.07.018_bib76","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib77","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2007.01.016","article-title":"Ferritin in autoimmune diseases","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-291X(90)91466-6","article-title":"Interleukin 1 induces ferritin heavy chain in human muscle cells","volume":"169","author":"Wei","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2018.07.018_bib79","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0167-4889(00)00066-5","article-title":"Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool","volume":"1497","author":"Pi\u00f1ero","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2018.07.018_bib80","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ni.2060","article-title":"Inflammation meets cancer, with NF-\u03baB as the matchmaker","volume":"12","author":"Ben-Neriah","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib81","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","article-title":"Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells","volume":"49","author":"Ruddell","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.07.018_bib82","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein","volume":"99","author":"Torti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.07.018_bib83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.blre.2008.08.001","article-title":"Ferritin for the clinician","volume":"23","author":"Knovich","year":"2009","journal-title":"Blood Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib84","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.07.018_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.autrev.2015.01.004","article-title":"Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease","volume":"14","author":"Ruscitti","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib86","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/cei.13057","article-title":"H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome","volume":"191","author":"Ruscitti","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib87","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cei.12826","article-title":"H-ferritin and CD68(+)\/H-ferritin(+) monocytes\/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease","volume":"186","author":"Ruscitti","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/cei.12738","volume":"183","author":"Ruscitti","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib89","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2007.11.003","article-title":"New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity","volume":"30","author":"Recalcati","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.018_bib90","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1084\/jem.20042433","article-title":"TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis","volume":"202","author":"Chen","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib91","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-065X.2009.00772.x","article-title":"The costimulatory role of TIM molecules","volume":"229","author":"Rodriguez-Manzanet","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib92","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.md.0000188009.47085.76","article-title":"Adult-onset Still disease as the cause of fever of unknown origin","volume":"84","author":"Crisp\u00edn","year":"2005","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2018.07.018_bib93","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/00365540600606564","article-title":"Fever of unknown origin in adults: evaluation of 144 cases in a non-university hospital","volume":"38","author":"Zenone","year":"2006","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib94","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.1780250607","article-title":"Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease","volume":"25","author":"Elkon","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset Still disease: manifestations, treatments, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2018.07.018_bib96","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10067-014-2614-2","article-title":"Cutaneous manifestations of adult-onset Still's disease: a case report and review of literature","volume":"35","author":"Cozzi","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib97","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00296-011-2330-z","article-title":"Cutaneous manifestations associated with adult-onset Still's disease: important diagnostic values","volume":"32","author":"Yamamoto","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2018.07.018_bib98","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1600-0560.2010.01570.x","article-title":"Persistent pruritic papules and plaques: a characteristic histopathologic presentation seen in a subset of patients with adult-onset and juvenile Still's disease","volume":"37","author":"Fortna","year":"2010","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.jaut.2018.07.018_bib99","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.semarthrit.2012.05.003","article-title":"Evanescent and persistent pruritic eruptions of adult-onset still disease: a clinical and pathologic study of 36 patients","volume":"42","author":"Lee","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/DAD.0b013e3180332826","article-title":"Unique histopathologic findings in a patient with adult-onset Still disease","volume":"29","author":"Wolgamot","year":"2007","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.jaut.2018.07.018_bib101","first-page":"28","article-title":"Clinical features and prognosis in 82 patients with adult-onset Still's disease","volume":"32","author":"Kim","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib102","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1097\/MD.0000000000000787","article-title":"The pathologic findings of skin, lymph node, liver, and bone marrow in patients with adult-onset still disease: a comprehensive analysis of 40 cases","volume":"94","author":"Kim","year":"2015","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2018.07.018_bib103","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/jcp.2004.018010","article-title":"Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy","volume":"57","author":"Jeon","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2018.07.018_bib104","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semarthrit.2010.12.006","article-title":"The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients","volume":"41","author":"Colina","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib105","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/s10165-008-0104-6","article-title":"Adult-onset Still's disease: a report of 28 cases and review of the literature","volume":"18","author":"Mehrpoor","year":"2008","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib106","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/RHU.0b013e3181b57199","article-title":"Liver abnormalities in adult onset Still's disease: a retrospective study of 77 Chinese patients","volume":"15","author":"Zhu","year":"2009","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib107","first-page":"192","article-title":"Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities","volume":"50","author":"Andr\u00e8s","year":"2003","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.jaut.2018.07.018_bib108","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00042737-200301000-00015","article-title":"Liver failure in adult Still's disease during corticosteroid treatment","volume":"15","author":"Ott","year":"2003","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib109","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s100670050161","article-title":"Acute hepatitis in adult Still's disease apparently resulting from oral iron substitution-a case report","volume":"19","author":"Maclachlan","year":"2000","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/qjmed\/94.10.568","article-title":"Liver biopsy is not useful in the diagnosis of adult Still's disease","volume":"94","author":"Andres","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.jaut.2018.07.018_bib111","first-page":"592","article-title":"Severe sore throat as a presenting symptom of adult onset Still's disease: a case series and review of the literature","volume":"24","author":"Nguyen","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib112","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2169\/internalmedicine.50.4180","article-title":"A case of adult onset Still's disease complicated with cryptogenic organizing pneumonia","volume":"50","author":"Sato","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib113","doi-asserted-by":"crossref","first-page":"e4258","DOI":"10.1097\/MD.0000000000004258","article-title":"Parenchymal lung involvement in adult-onset Still disease: a STROBE-compliant case series and literature review","volume":"95","author":"Gerfaud-Valentin","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2018.07.018_bib114","article-title":"Pulmonary arterial hypertension in adult-onset Still's disease: rapid response to anakinra","volume":"2012","author":"Campos","year":"2012","journal-title":"Case Rep. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib115","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10067-006-0382-3","article-title":"Pulmonary hypertension in a patient with adult-onset Stills disease","volume":"26","author":"Mubashir","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib116","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1053\/j.ajkd.2003.11.025","article-title":"Collapsing glomerulopathy in adult still's disease","volume":"43","author":"Kumar","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib117","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/rheumatology\/keh172","article-title":"Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil","volume":"43","author":"Bennett","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2018.07.018_bib118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10067-009-1331-8","article-title":"Successful treatment of refractory adult Still's disease and membranous glomerulonephritis with infliximab","volume":"29","author":"Babacan","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib119","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s10157-011-0546-6","article-title":"Necrotizing crescentic immunoglobulin A glomerulonephritis in adult-onset Still's disease","volume":"15","author":"Sayegh","year":"2011","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jaut.2018.07.018_bib120","first-page":"59","article-title":"Reversible posterior leukoencephalopathy syndrome in a case of adult onset Still's disease with concurrent thrombotic thrombocytopenic purpura: response to high dose immunoglobulin infusions","volume":"60","author":"Khobragade","year":"2012","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.jaut.2018.07.018_bib121","first-page":"1213","article-title":"Bilateral perception deafness in adult onset Still disease","volume":"25","author":"Zenone","year":"1996","journal-title":"Presse Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib122","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1007\/s00296-010-1529-8","article-title":"Aseptic meningitis in adult onset Still's disease","volume":"32","author":"Akkara Veetil","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2018.07.018_bib123","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.autrev.2015.01.007","article-title":"Seizing the clinical presentation in adult onset Still's disease. An extensive literature review","volume":"14","author":"Narula","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib124","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-006-0345-8","article-title":"Purtscher's-like retinopathy as an initial presentation of adult-onset Still's disease: a case report and review of the literature","volume":"26","author":"Liu","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","article-title":"Life-threatening complications of adult-onset Still's disease","volume":"33","author":"Efthimiou","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib126","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s10067-017-3830-3","article-title":"Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients","volume":"36","author":"Ruscitti","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib127","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.autrev.2016.09.016","article-title":"Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: analysis of 41 cases collected in 2 rheumatologic centers","volume":"16","author":"Ruscitti","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib128","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.07.018_bib129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib130","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib131","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03009742.2016.1167951","article-title":"Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases","volume":"46","author":"Batu","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib132","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.170955","article-title":"Macrophage activation syndrome in patients affected by adult onset Still's disease: analysis of survival rate and predictive factors in GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) cohort","author":"Ruscitti","year":"2018","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib133","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib134","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3899\/jrheum.161286","article-title":"Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease","volume":"44","author":"Ahn","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3346\/jkms.2004.19.1.137","article-title":"Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A","volume":"19","author":"Park","year":"2004","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.jaut.2018.07.018_bib136","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/OAEM.S135909","article-title":"Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments","volume":"10","author":"Hayakawa","year":"2017","journal-title":"Open Access Emerg. Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib137","first-page":"1194","article-title":"Disseminated intravascular coagulation in a case of adult onset Still's disease","volume":"38","author":"Sanada","year":"1997","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.jaut.2018.07.018_bib138","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.07.018_bib139","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MAJ.0b013e318191436e","article-title":"Thrombotic thrombocytopenic purpura and adult onset Still's disease","volume":"337","author":"Gopal","year":"2009","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jaut.2018.07.018_bib140","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1182\/blood-2003-11-4035","article-title":"Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.07.018_bib141","doi-asserted-by":"crossref","DOI":"10.3109\/s10165-012-0650-9","article-title":"A case of adult-onset Still's disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema","volume":"23","author":"Masuyama","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib142","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3346\/jkms.2009.24.1.155","article-title":"A case of adult-onset Still's disease complicated with diffuse alveolar hemorrhage","volume":"24","author":"Sari","year":"2009","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.jaut.2018.07.018_bib143","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11926-017-0651-y","article-title":"Diffuse alveolar hemorrhage in autoimmune diseases","volume":"19","author":"Mart\u00ednez-Mart\u00ednez","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jaut.2018.07.018_bib144","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1378\/chest.08-2084","article-title":"Diffuse alveolar hemorrhage","volume":"137","author":"Lara","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2018.07.018_bib145","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/1744666X.2015.1037287","article-title":"Presentation and diagnosis of adult-onset Still's disease: the implications of current and emerging markers in overcoming the diagnostic challenge","volume":"11","author":"Colafrancesco","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib146","article-title":"New markers for adult-onset Still's disease","author":"Mitrovic","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaut.2018.07.018_bib147","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(87)90204-2","article-title":"Increased serum ferritin levels in adult Still's disease","volume":"1","author":"Ota","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.07.018_bib148","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3899\/jrheum.080365","article-title":"Clinical features and prognosis of adult-onset still's disease: 61 cases from China","volume":"36","author":"Zeng","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib149","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3899\/jrheum.080537","article-title":"The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still's disease","volume":"36","author":"Lee","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib150","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease","volume":"28","author":"Fautrel","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib151","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.23415","article-title":"Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome","volume":"58","author":"Fardet","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib152","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.59.5.347","article-title":"Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease","volume":"59","author":"Vignes","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib153","article-title":"Efthimiou P Ferritin in adult-onset still's disease: just a useful innocent bystander?","volume":"2012","author":"Mehta","year":"2012","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.jaut.2018.07.018_bib154","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3899\/jrheum.161286","article-title":"Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease","volume":"44","author":"Ahn","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib155","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3899\/jrheum.141261","article-title":"Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"42","author":"Minoia","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib156","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00296-009-1137-7","article-title":"Clinical significance of 18F-fluoro-dexoxyglucose positron emission tomography in patients with adult-onset Still's disease: report of two cases and review of literatures","volume":"30","author":"Choe","year":"2010","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2018.07.018_bib157","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1445-5994.2012.02828.x","article-title":"Diagnostic value of 18F-FDG PET\/CT in patients with fever of unknown origin","volume":"42","author":"Kim","year":"2012","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.jaut.2018.07.018_bib158","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s10096-011-1440-6","article-title":"Place of (18F-FDG-PET with computed tomography in the diagnostic algorithm of patients with fever of unknown origin","volume":"31","author":"Crouzet","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib159","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/14397595.2013.850998","article-title":"Clinical value of (18)F-fluoro-dexoxyglucose positron emission tomography\/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature","volume":"24","author":"Yamashita","year":"2014","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib160","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9343(99)80318-0","article-title":"A controlled study of the long-term prognosis of adult Still's disease","volume":"98","author":"Sampalis","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2018.07.018_bib161","first-page":"844","article-title":"Clinical manifestations, disease course,and complications of adult-onset Still's disease in Taiwan","volume":"103","author":"Chen","year":"2004","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.jaut.2018.07.018_bib162","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2014.01.011","article-title":"Diagnosis and classification of adult Still's disease","volume":"48\u201349","author":"Mahroum","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.018_bib163","first-page":"1139","article-title":"Adult's still's disease: a review of 228 cases from the literature","volume":"14","author":"Ohta","year":"1987","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib164","unstructured":"Masson C, Le Loet X, Liote F, Dubost JJ, Boissier MC, Perroux-Goumy L, et al. Comparative study of 6 types of criteria in adult Still's disease. J. Rheumatol. 1196;23:495-497."},{"key":"10.1016\/j.jaut.2018.07.018_bib165","first-page":"827","article-title":"Adult onset Still's disease","volume":"13","author":"Calabro","year":"1986","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib166","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still's disease: clinical course and outcome","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib167","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib168","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2018.07.018_bib169","first-page":"331","article-title":"Adult onset Still's disease: review of 41 cases","volume":"29","author":"Riera","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2016.02.010","article-title":"Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: data from a large multicenter cohort","volume":"69","author":"Kalyoncu","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.07.018_bib171","first-page":"17","article-title":"Adult-onset Still's disease: current challenges and future prospects","volume":"8","author":"Siddiqui","year":"2016","journal-title":"Open Access Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib172","first-page":"33","article-title":"Treatment of adult-onset Still's disease: a review","volume":"11","author":"Jamilloux","year":"2014","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.jaut.2018.07.018_bib173","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib174","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3899\/jrheum.100766","article-title":"Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population-","volume":"38","author":"Jiang","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib175","first-page":"1055","article-title":"Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases","volume":"61","author":"Wouters","year":"1986","journal-title":"QJM"},{"key":"10.1016\/j.jaut.2018.07.018_bib176","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10067-010-1516-1","article-title":"Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases","volume":"29","author":"Kong","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib177","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.autrev.2017.07.017","article-title":"How I treat patients with adult onset Still's disease in clinical practice","volume":"16","author":"Govoni","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib178","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1586\/1744666X.2014.962996","article-title":"Methotrexate: an old new drug in autoimmune disease","volume":"10","author":"Cipriani","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib179","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.clinthera.2014.01.014","article-title":"Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms","volume":"36","author":"Cipriani","year":"2014","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.jaut.2018.07.018_bib180","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease","volume":"26","author":"Fautrel","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib181","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/s10165-008-0126-0","article-title":"Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease","volume":"19","author":"Mitamura","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib182","first-page":"295","article-title":"Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs","volume":"16","author":"Vignes","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib183","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0248-8663(96)80703-X","article-title":"Treatment of Still disease in adults with intravenous immunoglobulins","volume":"16","author":"Permal","year":"1995","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jaut.2018.07.018_bib184","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","article-title":"Adult-onset Still's disease: advances in the treatment","volume":"30","author":"Casta\u00f1eda","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib185","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/1744666X.2017.1375853","article-title":"Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies","volume":"13","author":"Ruscitti","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib186","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.07.018_bib187","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/03009742.2014.992949","article-title":"Efficacy and safety of biological agents in adult-onset Still's disease","volume":"44","author":"Cavalli","year":"2015","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib188","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s10067-015-3164-y","article-title":"A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?","volume":"35","author":"Dall'Ara","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib189","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acr.21901","article-title":"Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy","volume":"65","author":"Giampietro","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jaut.2018.07.018_bib190","first-page":"47","article-title":"Adult-onset Still's disease: clinical, serological and therapeutic considerations","volume":"31","author":"Iliou","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib191","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France","volume":"67","author":"Lequerr\u00e9","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib192","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-015-0228-7","article-title":"Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey","volume":"10","author":"Rossi-Semerano","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib193","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fphar.2016.00380","article-title":"A snapshot on the on-label and off-label use of the Interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study","volume":"7","author":"Vitale","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2018.07.018_bib194","doi-asserted-by":"crossref","first-page":"e1554","DOI":"10.1097\/MD.0000000000001554","article-title":"Efficacy of anakinra in refractory adult-onset Still's disease: multicenter study of 41 patients and literature review","volume":"94","author":"Ortiz-Sanju\u00e1n","year":"2015","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2018.07.018_bib195","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.2006.066381","article-title":"Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial","volume":"66","author":"Kalliolias","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib196","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3899\/jrheum.111549","article-title":"Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study","volume":"39","author":"Nordstr\u00f6m","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib197","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/ar3366","article-title":"Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study","volume":"13","author":"Laskari","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2018.07.018_bib198","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fphar.2017.00369","article-title":"Response to Interleukin-1 inhibitors in 140 Italian patients with adult-onset Still's disease: a multicentre retrospective observational study","volume":"8","author":"Colafrancesco","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2018.07.018_bib199","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.semarthrit.2017.06.006","article-title":"Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)","volume":"47","author":"Junge","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semarthrit.2012.03.004","article-title":"The use of Canakinumab, a novel IL-1\u03b2 long-acting inhibitor, in refractory adult-onset Still's disease","volume":"42","author":"Kontzias","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib201","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/annrheumdis-2012-201409","article-title":"IL-1 Trap rilonacept in refractory adult onset Still's disease","volume":"71","author":"Petryna","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib202","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/14397595.2014.899178","article-title":"Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease","volume":"26","author":"Bannai","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib203","doi-asserted-by":"crossref","first-page":"13477","DOI":"10.1038\/s41598-017-13639-y","article-title":"A pilot study on tocilizumab for treating refractory adult-onset Still's disease","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2018.07.018_bib204","first-page":"S64","article-title":"Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases","volume":"34","author":"Song","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/acr.20319","article-title":"Tocilizumab in refractory adult Still's disease","volume":"63","author":"Pu\u00e9chal","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jaut.2018.07.018_bib206","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/art.38398","article-title":"Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients","volume":"66","author":"Ortiz-Sanju\u00e1n","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib207","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3109\/s10165-011-0569-6","article-title":"Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan","volume":"22","author":"Suematsu","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib208","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10067-013-2381-5","article-title":"Tocilizumab for the treatment of adult-onset Still's disease: results from a case series","volume":"33","author":"Cipriani","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib209","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3899\/jrheum.130881","article-title":"Tocilizumab in adult-onset Still's disease: the Israeli experience","volume":"41","author":"Elkayam","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib210","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/art.10231","article-title":"Etanercept in the treatment of adult patients with Still's disease","volume":"46","author":"Husni","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.07.018_bib211","first-page":"329","article-title":"Infliximab in the treatment of adult Still's disease refractory to conventional therapy","volume":"19","author":"Cavagna","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib212","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/ard.60.90003.iii55","article-title":"Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences","volume":"60","author":"Kraetsch","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10067-003-0775-5","article-title":"Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients","volume":"23","author":"Kokkinos","year":"2004","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.07.018_bib214","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard.2004.024026","article-title":"Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases","volume":"64","author":"Fautrel","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib215","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease","author":"Gabay","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2018.07.018_bib216","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2018.07.018_bib217","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-stat signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jaut.2018.07.018_bib218","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/1744666X.2016.1189826","article-title":"Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis","volume":"12","author":"Iwata","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.07.018_bib219","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","article-title":"Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice","volume":"128","author":"Maschalidi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.07.018_bib220","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","article-title":"Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis","volume":"127","author":"Das","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.07.018_bib221","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1182\/blood-2016-02-697151","article-title":"Alleviating the storm: ruxolitinib in HLH","volume":"127","author":"La Ros\u00e9e","year":"2016","journal-title":"Blood"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118303950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118303950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:20:13Z","timestamp":1760257213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118303950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":221,"alternative-id":["S0896841118303950"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.07.018","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review on adult onset Still's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}